Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Novel role of the Mu-opioid receptor in pancreatic cancer: potential link between opioid use and cancer progression

Molecular and Cellular Biochemistry(2022)10.1007/s11010-022-04377-5Source: DataRank Database

Novel role of the Mu-opioid receptor in pancreatic cancer: potential link between opioid use and cancer progression is a research paper published in Molecular and Cellular Biochemistry (2022). On theSindex it has a DataRank of 0. It has been cited 16 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

16 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.98)OA: closedTopics (44)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Usman Barlass,Andrew Armstrong ORCID,Maliha Shaikh,Faraz Bishehsari ORCID,Muhammad R. Haque ORCID

Live enrichment

PubMed:35138511 OpenAlex:https://openalex.org/W4210848332

National Institutes of Health

Grant: AA025387

Swim Across America Organization grant

Grant: 5UL1TR002389-02

ITM 2.0: Advancing Translational Science in Metropolitan Chicago

National Institutes of Health

Grant: 5K23AA025387-05

Abnormal Food Timing and Circadian Dyssynchrony in Alcohol Induced Colon Carcinogenesis

FWCI

1.98

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

2026

closedLicense: Springer TDM

publisherhttps://link.springer.com/content/pdf/10.1007/s11010-022-04377-5.pdf

publisherhttps://link.springer.com/article/10.1007/s11010-022-04377-5/fulltext.html

journalhttps://doi.org/10.1007/s11010-022-04377-5

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35138511

Fields of Study

Cancer, Stress, Anesthesia, and Immune ResponseNeuropeptides and Animal PhysiologyPain Management and Opioid Use0301 basic medicine03 medical and health sciencesAnalgesics, OpioidAnimalsCell LineHumansMiceMorphinePancreatic NeoplasmsReceptors, Opioid, mu

MeSH Terms

Analgesics, OpioidAnimalsCell LineHumansMorphinePancreatic NeoplasmsReceptors, Opioid, muMice

Keywords

Pancreatic cancerMorphineMedicineOpioidCancerμ-opioid receptorOpioid receptorCancer researchCancer cellAgonistTumor progressionReceptorStimulationPharmacologyInternal medicineMorAnalgesics, OpioidPancreatic NeoplasmsMiceReceptors, Opioid, muAnimalsHumansCell Line

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Novel role of the Mu-opioid receptor in pancreatic cancer: potential link between opioid use and cancer progression

FAIR Checklist

Authors (5)

Funding (3 grants)

Impact

Open Access

Topics